MYC and diffuse large B-cell lymphoma: MYC is a proto-oncogene controlling the cell growth, survival, and cell cycle, among other cellular functions, and between 5–20% of DLBCL patients harbor MYC rearrangements that lead to unregulated overexpression and an aggressive disease course [53,54].